logo

For the Inventor, By the Inventor

Hiromachi, Japan

Masao Kuroda

This inventor holds 18 USPTO granted patents, primarily in Cholesterol Synthesis. Top assignees: Sankyo Company, Limited, Hitachi Medical Corporation, Hitachi, Ltd.. Active years: 1976-1997.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Masao Kuroda. Retrieved from https://idiyas.com/inventor/masao-kuroda

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 18

% Patents Active = 100.0

Average Co-Inventor Count = 4.1

ph-index = 10

Forward Citations = 393(Granted Patents)


Location History:

  • Tokyo, JA (1976 - 1978)
  • Nishioizumimachi, JP (1980)
  • Nakano, JP (1987)
  • Matsudo, JP (1987)
  • Tokyo, JP (1978 - 1992)
  • Hiromachi, JP (1982 - 1997)

Company Filing History:

goldMedal9 out of 613 
 
Sankyo Company, Limited
 patents
silverMedal6 out of 900 
 
Hitachi Medical Corporation
 patents
bronzeMedal3 out of 42,743 
 
Hitachi, Ltd.
 patents

Years Active: 1976-1997

Loading Chart...
Areas of Expertise:
Octahydronaphthalene
Cholesterol Synthesis
Nuclear Magnetic Resonance
Ultrasonic Technology
Hydroxy-ML-236B
Acoustic Beamformer
Monacolin K
Imaging Apparatus
Physiologically Active Substances
Ultrasonic Tomography
Preparation Process
Phasing Circuit
18 patents (USPTO):Explore Patents
1. 5658942 - Octahydronaphthalene oxime compounds for cholesterol synthesis inhibition (1997-08-19),
2. 5403860 - Octahydronaphthalene oxime compounds for cholesterol synthesis inhibition (1995-04-04),
3. 5272174 - Hydroxy-ML-236B derivatives, their preparation and use (1993-12-21),
4. 5153124 - Hydroxyl-ML-236B derivatives, their preparation and use (1992-10-06),
5. 4997848 - Octahydronaphthalene oxime derivatives for cholesterol synthesis (1991-03-05),
6. 4683433 - Imaging method and apparatus using nuclear magnetic resonance (1987-07-28),
7. 4672320 - Imaging apparatus and method using nuclear magnetic resonance (1987-06-09),
8. 4643028 - Phasing circuit for use in a scanning type ultrasonic equipment (1987-02-17),
9. 4625171 - Imaging apparatus using nuclear magnetic resonance (1986-11-25),
10. 4604472 - Octahydronaphthalene derivatives and their preparation (1986-08-05),
11. 4357690 - Switch circuit for exciting ultrasonic transducer elements (1982-11-02),
12. 4323648 - Preparation of Monacolin K (1982-04-06),
13. 4254662 - Multiple acoustic beamformer step scanner (1981-03-10),
14. 4215584 - Method for transmission and reception of ultrasonic beams using (1980-08-05),
15. 4099419 - Ultrasonic tomography apparatus (1978-07-11),

Title: The Innovative Contributions of Masao Kuroda

Introduction

Masao Kuroda is a prominent inventor based in Hiromachi, Japan. He has made significant contributions to the field of chemistry, particularly in the development of compounds that inhibit cholesterol synthesis. With a total of 18 patents to his name, Kuroda's work has implications for treating cholesterol-related disorders in both humans and animals.

Latest Patents

Kuroda's latest patents focus on octahydronaphthalene oxime compounds that serve as inhibitors for cholesterol synthesis. These compounds are characterized by a specific formula where R can represent hydrogen, methyl, or hydroxy, while X can be an alkyl, alkenyl, cycloalkyl, aryl, or aralkyl group. The compounds exhibit valuable antihypercholesteremic activities, making them potential candidates for treating disorders arising from blood cholesterol imbalances.

Career Highlights

Throughout his career, Kuroda has worked with notable companies such as Sankyo Company, Limited and Hitachi Medical Corporation. His experience in these organizations has allowed him to refine his expertise in the field of pharmaceutical chemistry and contribute to innovative solutions for health-related issues.

Collaborations

Kuroda has collaborated with esteemed colleagues, including Yoshio Tsujita and Toshio Kondo. These partnerships have further enhanced his research and development efforts, leading to advancements in the understanding and treatment of cholesterol-related conditions.

Conclusion

Masao Kuroda's innovative work in developing octahydronaphthalene oxime compounds highlights his significant contributions to medical chemistry. His patents and collaborations reflect a commitment to addressing critical health challenges related to cholesterol.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…